Mig-6 is a negative regulator of the epidermal growth factor receptor signal
- PMID: 11843178
- DOI: 10.1515/BC.2001.200
Mig-6 is a negative regulator of the epidermal growth factor receptor signal
Abstract
In contrast to signal generation and transmission, the mechanisms and molecules that negatively regulate receptor tyrosine kinase (RTK) signaling are poorly understood. Here we characterize Mig-6 as a novel negative feedback regulator of the epidermal growth factor receptor (EGFR) and potential tumor suppressor. Mig-6 was identified in a yeast two-hybrid screen with the kinase active domain of the EGFR as bait. Upon EGF stimulation Mig-6 binds to the EGFR involving a highly acidic region between amino acids 985-995. This interaction is kinase activity-dependent, but independent of tyrosine 992. Mig-6 overexpression results in reduced activation of the mitogenactivated protein kinase ERK2 in response to EGF, but not FGF or PDGF, stimulation and in enhanced receptor internalization without affecting the rate of degradation. The induction of Mig-6 mRNA expression in response to EGF, but not FGF, indicates the existence of a negative regulatory feedback loop. Consistent with these findings, a possible role as tumor suppressor is indicated by Mig-6-mediated inhibition of EGFR overexpression-induced transformation of Rati cells.
Similar articles
-
Unique role of SNT-2/FRS2beta/FRS3 docking/adaptor protein for negative regulation in EGF receptor tyrosine kinase signaling pathways.Oncogene. 2006 Oct 19;25(49):6457-66. doi: 10.1038/sj.onc.1209656. Epub 2006 May 15. Oncogene. 2006. PMID: 16702953
-
EGFR and FGFR signaling through FRS2 is subject to negative feedback control by ERK1/2.Biol Chem. 2003 Aug;384(8):1215-26. doi: 10.1515/BC.2003.134. Biol Chem. 2003. PMID: 12974390
-
Transcriptional regulation of signal regulatory protein alpha1 inhibitory receptors by epidermal growth factor receptor signaling.Cancer Res. 2004 Sep 15;64(18):6444-52. doi: 10.1158/0008-5472.CAN-04-0256. Cancer Res. 2004. PMID: 15374953
-
Epidermal growth factor receptor (EGFR) signaling in cancer.Gene. 2006 Jan 17;366(1):2-16. doi: 10.1016/j.gene.2005.10.018. Epub 2005 Dec 27. Gene. 2006. PMID: 16377102 Review.
-
Mig-6, signal transduction, stress response and cancer.Cell Cycle. 2007 Mar 1;6(5):507-13. doi: 10.4161/cc.6.5.3928. Epub 2007 Mar 31. Cell Cycle. 2007. PMID: 17351343 Review.
Cited by
-
Epithelial wound healing in inflammatory bowel diseases: the next therapeutic frontier.Transl Res. 2021 Oct;236:35-51. doi: 10.1016/j.trsl.2021.06.001. Epub 2021 Jun 12. Transl Res. 2021. PMID: 34126257 Free PMC article. Review.
-
DNA damage alters EGFR signaling and reprograms cellular response via Mre-11.Sci Rep. 2022 Apr 6;12(1):5760. doi: 10.1038/s41598-022-09779-5. Sci Rep. 2022. PMID: 35388101 Free PMC article.
-
Mig-6 is required for appropriate lung development and to ensure normal adult lung homeostasis.Development. 2009 Oct;136(19):3347-56. doi: 10.1242/dev.032979. Epub 2009 Aug 26. Development. 2009. PMID: 19710174 Free PMC article.
-
Androgen-Induced MIG6 Regulates Phosphorylation of Retinoblastoma Protein and AKT to Counteract Non-Genomic AR Signaling in Prostate Cancer Cells.Biomolecules. 2022 Jul 29;12(8):1048. doi: 10.3390/biom12081048. Biomolecules. 2022. PMID: 36008945 Free PMC article.
-
Differential roles of ERRFI1 in EGFR and AKT pathway regulation affect cancer proliferation.EMBO Rep. 2018 Mar;19(3):e44767. doi: 10.15252/embr.201744767. Epub 2018 Jan 15. EMBO Rep. 2018. PMID: 29335246 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous